[{"NetIncomeLoss_1_Q1_USD":38028962.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":21375000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":291745358.0,"AssetsCurrent_0_Q1_USD":99501.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":5040155.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":40050.0,"IncomeTaxesPaid_1_Q1_USD":null,"OperatingCostsAndExpenses_1_Q1_USD":2050121.0,"InterestIncomeOther_1_Q1_USD":23622.0,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":20607461.0,"PreferredStockSharesOutstanding_0_Q1_shares":null,"ProceedsFromRelatedPartyDebt_1_Q1_USD":120000.0,"PrepaidTaxes_0_Q1_USD":10381.0,"Liabilities_0_Q1_USD":39765155.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":28654.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0094,"FairValueAdjustmentOfWarrants_1_Q1_USD":-40007500.0,"OtherPrepaidExpenseCurrent_0_Q1_USD":60466.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_0_Q1_USD":11.5,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":120000.0,"AssetsHeldInTrustNoncurrent_0_Q1_USD":291784977.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_1_Q1_USD":-286042.0,"BusinessAcquisitionPercentageOfVotingInterestsAcquired_0_Q1_pure":0.5,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":1630283.0,"FederalDepositInsuranceCorporationPremiumExpense_1_Q1_USD":250000.0,"ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_1_Q1_USD":5000000.0,"AssetsHeldInTrust_0_Q1_USD":291784977.0,"Assets_0_Q1_USD":291927576.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"PreferredStockSharesIssued_0_Q1_shares":null,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":null,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":-39582937.0,"NonoperatingIncomeExpense_1_Q1_USD":40035383.0,"LiabilitiesCurrent_0_Q1_USD":5160155.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-446092.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":37985262.0,"NotesPayableRelatedPartiesClassifiedCurrent_0_Q1_USD":120000.0,"IncreaseDecreaseInDerivativeLiabilities_1_Q1_USD":-40007500.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-39583656.0,"TaxesPayableCurrent_0_Q1_USD":null,"StockholdersEquity_0_Q1_USD":-39582937.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-43700.0,"UnrealizedGainLossOnSecurities_1_Q1_USD":null,"EarningsPerShareBasicAndDiluted_1_Q1_USD":0.0,"SharePrice_0_Q1_USD":10.08,"DerivativeLiabilitiesNoncurrent_0_Q1_USD":23792500.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":291927576.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-43700.0,"PreferredStockValue_0_Q1_USD":null,"InvestmentIncomeInterest_1_Q1_USD":27883.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":null,"OperatingIncomeLoss_1_Q1_USD":-2050121.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":26254.0,"ProceedsFromSaleOfTrustAssetsToPayExpenses_1_Q1_USD":40050.0,"DeferredOfferingCosts_0_Q1_USD":16473117.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.11,"Ticker":"CELU","CIK":"1752828","name":"GX ACQUISITION CORP.","OfficialName":"Celularity Inc. Class A Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1622347796.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210524"}]